BTAI logo

BioXcel Therapeutics (BTAI) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$65.22 M
-$128.50 M-66.33%

December 31, 2023


Summary


Performance

BTAI Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBTAIbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$40.39 M
-$15.88 M-28.23%

September 30, 2024


Summary


Performance

BTAI Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBTAIbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

BTAI Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-66.3%-38.1%
3 y3 years-69.4%-84.0%
5 y5 years+53.2%+0.3%

BTAI Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-72.0%at low-82.7%at low
5 y5-year-72.0%+101.1%-85.2%+24.6%
alltimeall time-72.0%-100.0%-85.2%+4453.2%

BioXcel Therapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$40.39 M(-28.2%)
Jun 2024
-
$56.27 M(-24.1%)
Mar 2024
-
$74.14 M(+13.7%)
Dec 2023
$65.22 M(-66.3%)
$65.22 M(-27.5%)
Sep 2023
-
$89.96 M(-29.5%)
Jun 2023
-
$127.55 M(-22.9%)
Mar 2023
-
$165.52 M(-14.6%)
Dec 2022
$193.72 M(-16.8%)
$193.72 M(-16.6%)
Sep 2022
-
$232.31 M(-0.5%)
Jun 2022
-
$233.45 M(+16.5%)
Mar 2022
-
$200.44 M(-14.0%)
Dec 2021
$232.97 M(+9.3%)
$232.97 M(-7.9%)
Sep 2021
-
$252.91 M(-7.4%)
Jun 2021
-
$273.06 M(+40.7%)
Mar 2021
-
$194.01 M(-9.0%)
Dec 2020
$213.12 M
$213.12 M(-8.7%)
DateAnnualQuarterly
Sep 2020
-
$233.43 M(+256.4%)
Jun 2020
-
$65.50 M(-18.2%)
Mar 2020
-
$80.08 M(+147.0%)
Dec 2019
$32.43 M(-23.8%)
$32.43 M(-19.4%)
Sep 2019
-
$40.25 M(+34.3%)
Jun 2019
-
$29.96 M(-17.4%)
Mar 2019
-
$36.30 M(-14.7%)
Dec 2018
$42.56 M(+4698.8%)
$42.56 M(-9.7%)
Sep 2018
-
$47.12 M(-6.4%)
Jun 2018
-
$50.35 M(-9.2%)
Mar 2018
-
$55.47 M(+6153.1%)
Dec 2017
$887.00 K(>+9900.0%)
$887.00 K
Dec 2016
$0.00(-100.0%)
-
Jul 2016
$348.50 K(+25.9%)
-
Jul 2015
$276.90 K(+406.2%)
-
Jul 2014
$54.70 K
-

FAQ

  • What is BioXcel Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for BioXcel Therapeutics?
  • What is BioXcel Therapeutics annual cash & cash equivalents year-on-year change?
  • What is BioXcel Therapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for BioXcel Therapeutics?
  • What is BioXcel Therapeutics quarterly cash and cash equivalents year-on-year change?

What is BioXcel Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of BTAI is $65.22 M

What is the all time high annual cash & cash equivalents for BioXcel Therapeutics?

BioXcel Therapeutics all-time high annual cash & cash equivalents is $232.97 M

What is BioXcel Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, BTAI annual cash & cash equivalents has changed by -$128.50 M (-66.33%)

What is BioXcel Therapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of BTAI is $40.39 M

What is the all time high quarterly cash and cash equivalents for BioXcel Therapeutics?

BioXcel Therapeutics all-time high quarterly cash and cash equivalents is $273.06 M

What is BioXcel Therapeutics quarterly cash and cash equivalents year-on-year change?

Over the past year, BTAI quarterly cash and cash equivalents has changed by -$24.83 M (-38.08%)